Peter Damsbo, MD

Peter Damsbo, MD

Peter Damsbo, MD, from Copenhagen University, has more than 25 years of experience from life science industry and science, including several years in the United States heading up clinical development of diabetes products for Novo Nordisk. Key positions prior to joining Kinexum include Chief Development Officer at Zealand Pharma, Vice President Clinical Drug Development at Novo Nordisk Headquarter, Medical Director Diabetes at Novo Nordisk USA, and Research Fellow at the Steno Diabetes Center focused on research in Type 2 diabetes (more than 20 peer reviewed papers). During his industry career, Peter Damsbo has carried 3 medical projects from preclinical phase through to worldwide registration, including writing the expert reports and presented at meetings and hearings with Health authorities. He has experience in medical device development and conducted numerous drug concept evaluations as well as been involved in drug licensing deals and due diligence processes.   Peter Damsbo has experience in interacting with the health authorities in a number of countries, including most notably FDA and EMEA. He has Attended the Advanced Management Program at INSEAD, Managing Medical Product Innovation at SIMI and Product Business Planning: ‘How do we extract maximum value from our Projects’ by Prof. Ralph Boscheck, IMD   His medical expertise spans over several therapeutic areas, including diabetes, obesity, and metabolic diseases and inflammatory diseases, and includes medical devices across the areas. He is partner in Ventac Partners, a venture catalyst in life science and is associated to the Danish-based KLIFO’s Drug Development Counselling groups.

Leadership List

Officers

G. Alexander Fleming, MD
Founder and Executive Chairman

Thomas Seoh, J.D.
President and Chief Executive Officer

Brian Oscherwitz, MBA, PMP
Chief Operating Officer

 

Clinical Development

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Brian E. Harvey, MD, Ph.D

Charles Alexander, MD

Doug Muchmore, MD

Giora Davidai, MD

Gordon B. Cutler, Jr., M.D.

Grant Williams, MD

Guenther Karmann, Ph.D

John K. Whisnant, Jr, MD

Michael Trautmann, MD

Mustafa A. Noor, MD, FACP

Peter Damsbo, MD

Ramachandra (Ram) G. Naik, M.D.

Simon Bruce, MD

Theo Gana, MD, Ph.D

Todd J. Lorenz, MD

 

Regulatory Strategy and Operations

G. Alexander Fleming, MD

Arthur Santora, MD, Ph.D

Asoke Mukherjee, Ph.D

Brian E. Harvey, MD, Ph.D

Catherine Bernard, Ph.D

David Reinhold Brill, Ph.D

Dia Hill, B.S.

Frances Mielach, Ph.D, RP.h

Gabrielle Wiederkehr, MSc

Grant Williams, MD

Joshua Sharlin, Ph.D

Michael Sharp, Ph.D 

Susan Manley, MS

 

Biostatistics

Alan Fisher, DrPH

 

EU Regulatory

Catherine Bernard, Ph.D

Gabrielle Wiederkehr, MSc

Michael Trautmann, MD

 

Clinical Operations/Project Management

Brian Oscherwitz, MBA, PMP

Chris Yun, B.S.

Gabrielle Wiederkehr, MSc

Julie Waltz Gerlach, B.S.N., M.P.H., R.A.C.

Susan Manley, MS

 

Pre-Clinical

Asoke Mukherjee, Ph.D

Dave Edwards, Ph.D

Frances Mielach, Ph.D, RP.h

Joy Cavagnaro, Ph.D

Michael B. Zemel, Ph.D.

Virgil Whitehurst, Ph.D

 

CMC, Formulation/Process Development & Sourcing

Anand Khedkar, Ph.D

David Bergstrom, Ph.D

Jo Van Betsbrugge, PhD

Knut Zellerhoff, Ph.D

Robert Kaster, RPh., ASQ-CQA

 

Medical Device

Michael Sharp, Ph.D

 

QA/QC

Brian Oscherwitz, MBA, PMP

Jennifer Zhao, B.S.

 

Medical Writing/Electronic Submissions

Jennifer Zhao, B.S.

Kristi Hultberg, B.S.

Sandor Bernath, Ph.D, MBA

 

Botanicals

Jinhui Dou, Ph.D.

 

Government Relations and Public Affairs

Scot Faulkner, MPA

 

Defense & National Security Practice

Dean E.Calcagni, MD

 

Commercialization and Business & Corporate Strategy

Brian Oscherwitz, MBA, PMP

Lisa Jansa, MBA

Martin Lafontaine

Thomas Seoh, J.D.